Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for EDARAVONE
- The Efficacy and Safety of Edaravone Dexborneol Sequential Therapy in the Treatment of Patients With AIS
- Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke
- Extension Study Following the Studies MT-1186-A03 or A04 to Evaluate the Safety of Oral Edaravone in Subjects With ALS
- Edaravone in the Treatment of Aquaporin-4 Antibody-positive Optic Neuritis
- A Phase IIb, Randomized, Prospective, Double-Blind, Placebo-Controlled Study, to Evaluate Safety, Tolerability and Efficacy of PrimeC in Subjects With ALS
- Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Subjects (Food Effect Study)
- ASURE: Alzheimer Study Using oRal Edaravone
- Treatment of Acute Ischemic STroke With Edaravone Dexborneol II
- Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS)
- SPT-07A Injection in Patients With Acute Ischemic Stroke (AIS): A Phase III Clinical Trial
- Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS
- Thrombolysis Combined With Edaravone Dexborneol on Hemorrhagic Transformation for Acute Ischemic Stroke
- Protective Effects of Edaravone Dexborneol
- Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke
- A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS)
- Edaravone Dexborneol for Treatment of Acute Ischemic Stroke With Endovascular Therapy in Extended Time Windows
- Comparative Bioavailability Study of Oral Edaravone Administered Orally and Via a Nasogastric Tube
- Edaravone Dexborneol for Treatment of Hypertensive Intracerebral Hemorrhage
- Improving Neuroprotective Strategy for Ischemic Stroke With Sufficient Recanalization After Thrombectomy by Edaravone Dexborneol
- Impact of the Combined Treatment of Liposomed Polyphenols With G04CB02 on the ALS Patients
- Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS)
- Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS
- Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects
- Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study)
- Study of Oral Edaravone in Healthy Adult Males
- The Safety and Effectiveness of Cholinergic Receptor Block Therapy in the Treatment of ALS
- A Study of TTYP01 in Healthy Adult Subjects
- Clinical Pharmacology Study of Oral Edaravone in Amyotrophic Lateral Sclerosis Patients With Gastrostomy
- Safety, Tolerance and Pharmacokinetics Study of Compound Edaravone Injection
- Drug-drug Interaction Study Between Edaravone and 2-Aminoethanesulfonic Acid in Compound Edaravone Injection
- Trial of Oxaloacetate in ALS
- Improving Neuroprotective Strategy for Ischemic Stroke With Sufficient Recanalization After Thrombectomy by Intra-arterial Cocktail Therapy (INSIST-CT)
- Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis
- Safety Study of Oral Edaravone Administered in Subjects With ALS
- A Study to Evaluate the Effect of MCI-186 at Therapeutic and Supra-Therapeutic Doses on the QT Interval(QT)/Corrected QT Interval(QTc) Interval in Healthy Subjects
- Efficacy and Safety of Nerve Growth Factor or Edaravone on Alcohol-induced Brain Injury
- PK Study in Subjects With Severe Hepatic Impairment
- Safety, Tolerability and Pharmacokinetics of Y-2(Edaravone And Borneol) Sublingual Tablet
- Safety and Efficacy of Ranolazine for the Treatment of Amyotrophic Lateral Sclerosis
- Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Hepatic Impairment
- Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Renal Impairment
- Treatment Effect of Edaravone in Patients With Amyotrophic Lateral Sclerosis (ALS)
- A Clinical Trial of Pimozide in Patients With Amyotrophic Lateral Sclerosis (ALS)
- A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)
- Edaravone on the Ischemia-Reperfusion(I/R) Injury in Kidney Transplantation Patients
- Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke
- Compound Edaravone Injection for Acute Ischemic Stroke
- Mechanism and Early Intervention Research on ALI During Emergence Surgery of Acute Stanford A Aortic Dissection
- Effect of Edaravone on Radiation-induced Temporal Lobe Necrosis
- Autologous Hematopoietic Stem Cell Transplantation in Ischemic Stroke
- Safety and Pharmacokinetics of MCI-186 in Subjects With Acute Ischemic Stroke
- Expanded Controlled Study of Safety and Efficacy of MCI-186 in Patients With Amyotrophic Lateral Sclerosis (ALS)
- Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) Who Met Severity Classification III
- Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS)
- Pilot Study of Edaravone to Treat Acute Myocardial Infarction
- Edaravone-Sodium Ozagrel Comparative Post-Marketing Study on Acute Ischemic Stroke
- Edaravone and Argatroban Stroke Therapy Study for Acute Ischemic Stroke
Clinical trials list
click for details